B-cell Lymphoproliferative Disorder
📧 Sign up to get email alerts when something new happens for B-cell Lymphoproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Epcoritamab in Previously Treated WM [Phase 2]
Epcoritamab is being studied in a Phase 2 trial for patients with Waldenström macroglobulinemia who have received prior treatment; the study…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia [Phase 2]
Phase 2 study evaluating safety and efficacy of pacritinib in relapsed or refractory Waldenström macroglobulinemia; the trial is currently r…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay
Pivotal clinical study update evaluating the accuracy of Invivoscribe's IdentiClone Dx IGH Assay for B-cell lymphoproliferative disorders.